{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:17:20Z","timestamp":1777393040244,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The major risk factor for melioidosis, an infectious disease caused by <jats:italic>B. pseudomallei<\/jats:italic>, is diabetes mellitus. More than half of diabetic melioidosis patients in Thailand were prescribed glibenclamide. Recent evidence demonstrates that glibenclamide reduces pro-inflammatory cytokine production by polymorphonuclear neutrophils (PMNs) of diabetic individuals in response to this bacterial infection. However, the mechanisms by which glibenclamide affects cytokine production are unknown. We found that PMNs from glibenclamide-treated diabetic individuals infected with live <jats:italic>B. pseudomallei in vitro<\/jats:italic> showed lower free glutathione (GSH) levels compared with those of healthy individuals. Glibenclamide decreased GSH levels and glutathione peroxidase (GPx) of PMNs after exposed to live <jats:italic>B. pseudomallei<\/jats:italic>. Moreover, glibenclamide reduced cytokine production and migration capacity of infected PMNs, whereas GSH could restore these functions. Taken together, our data show a link between the effect of glibenclamide on GSH and PMN functions in response to <jats:italic>B. pseudomallei<\/jats:italic> that may contribute to the susceptibility of diabetic individuals to <jats:italic>B. pseudomallei<\/jats:italic> infection.<\/jats:p>","DOI":"10.1038\/srep34794","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T09:55:49Z","timestamp":1475834149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione"],"prefix":"10.1038","volume":"6","author":[{"given":"Chidchamai","family":"Kewcharoenwong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darawan","family":"Rinchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnone","family":"Nithichanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Ato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganjana","family":"Lertmemongkolchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,7]]},"reference":[{"key":"BFsrep34794_CR1","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","volume":"341","author":"N Joshi","year":"1999","unstructured":"Joshi, N., Caputo, G. M., Weitekamp, M. R. & Karchmer, A. W. Infections in Patients with Diabetes Mellitus. New England Journal of Medicine 341, 1906\u20131912 (1999).","journal-title":"New England Journal of Medicine"},{"key":"BFsrep34794_CR2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.26.2.510","volume":"26","author":"BR Shah","year":"2003","unstructured":"Shah, B. R. & Hux, J. E. Quantifying the Risk of Infectious Diseases for People With Diabetes. Diabetes Care 26, 510\u2013513 (2003).","journal-title":"Diabetes Care"},{"key":"BFsrep34794_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","volume":"18","author":"AC Cheng","year":"2005","unstructured":"Cheng, A. C. & Currie, B. J. Melioidosis: Epidemiology, Pathophysiology, and Management. Clin. Microbiol. Rev. 18, 383\u2013416 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFsrep34794_CR4","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.cmi.2015.09.024","volume":"22","author":"C Lim","year":"2016","unstructured":"Lim, C., Peacock, S. J. & Limmathurotsakul, D. Association between activities related to routes of infection and clinical manifestations of melioidosis. Clin Microbiol Infect 22, 79 e71\u201373 (2016).","journal-title":"Clin Microbiol Infect"},{"key":"BFsrep34794_CR5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(03)13374-0","volume":"361","author":"NJMelioidosis White","year":"2003","unstructured":"White, N. J. Melioidosis. The Lancet 361, 1715\u20131722 (2003).","journal-title":"The Lancet"},{"key":"BFsrep34794_CR6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1086\/520223","volume":"29","author":"Y Suputtamongkol","year":"1999","unstructured":"Suputtamongkol, Y. et al. Risk Factors for Melioidosis and Bacteremic Melioidosis. Clinical Infectious Diseases 29, 408\u2013413 (1999).","journal-title":"Clinical Infectious Diseases"},{"key":"BFsrep34794_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/380456","volume":"38","author":"AC Cheng","year":"2004","unstructured":"Cheng, A. C., Stephens, D. P., Anstey, N. M. & Currie, B. J. Adjunctive Granulocyte Colony Stimulating Factor for Treatment of Septic Shock Due to Melioidosis. Clinical Infectious Diseases 38, 32\u201337 (2004).","journal-title":"Clinical Infectious Diseases"},{"key":"BFsrep34794_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1086\/509810","volume":"195","author":"A Easton","year":"2007","unstructured":"Easton, A., Haque, A., Chu, K., Lukaszewski, R. & Bancroft, G. J. A Critical Role for Neutrophils in Resistance to Experimental Infection with Burkholderia pseudomallei. Journal of Infectious Diseases 195, 99\u2013107 (2007).","journal-title":"Journal of Infectious Diseases"},{"key":"BFsrep34794_CR9","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1128\/IAI.73.2.1106-1115.2005","volume":"73","author":"SL Reckseidler-Zenteno","year":"2005","unstructured":"Reckseidler-Zenteno, S. L., DeVinney, R. & Woods, D. E. The Capsular Polysaccharide of Burkholderia pseudomallei Contributes to Survival in Serum by Reducing Complement Factor C3b Deposition. Infect. Immun. 73, 1106\u20131115 (2005).","journal-title":"Infect. Immun."},{"key":"BFsrep34794_CR10","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/gb-2009-10-11-r127","volume":"10","author":"R Pankla","year":"2009","unstructured":"Pankla, R. et al. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol 10, R127 (2009).","journal-title":"Genome Biol"},{"key":"BFsrep34794_CR11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/IAI.00503-08","volume":"77","author":"S Chanchamroen","year":"2009","unstructured":"Chanchamroen, S., Kewcharoenwong, C., Susaengrat, W., Ato, M. & Lertmemongkolchai, G. Human Polymorphonuclear Neutrophil Responses to Burkholderia pseudomallei in Healthy and Diabetic Subjects. Infect. Immun. 77, 456\u2013463 (2009).","journal-title":"Infect. Immun."},{"key":"BFsrep34794_CR12","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/srep03363","volume":"3","author":"C Kewcharoenwong","year":"2013","unstructured":"Kewcharoenwong, C. et al. Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection. Sci Rep 3, 3363 (2013).","journal-title":"Sci Rep"},{"key":"BFsrep34794_CR13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1194\/jlr.M300358-JLR200","volume":"45","author":"TJ Nieland","year":"2004","unstructured":"Nieland, T. J. et al. Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide. J Lipid Res 45, 1256\u20131265 (2004).","journal-title":"J Lipid Res"},{"key":"BFsrep34794_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","volume":"187","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome. J Cell Biol 187, 61\u201370 (2009).","journal-title":"J Cell Biol"},{"key":"BFsrep34794_CR15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/cid\/ciq192","volume":"52","author":"GC Koh","year":"2011","unstructured":"Koh, G. C. et al. Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis 52, 717\u2013725 (2011).","journal-title":"Clin Infect Dis"},{"key":"BFsrep34794_CR16","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1172\/JCI57817","volume":"122","author":"KS Tan","year":"2012","unstructured":"Tan, K. S. et al. Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest 122, 2289\u20132300 (2012).","journal-title":"J Clin Invest"},{"key":"BFsrep34794_CR17","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.bbagen.2012.10.012","volume":"1830","author":"D Morris","year":"2013","unstructured":"Morris, D. et al. Glutathione and infection. Biochim Biophys Acta 1830, 3329\u20133349 (2013).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep34794_CR18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2249.2011.04552.x","volume":"168","author":"C Guerra","year":"2012","unstructured":"Guerra, C. et al. Control of Mycobacterium tuberculosis growth by activated natural killer cells. Clin Exp Immunol 168, 142\u2013152 (2012).","journal-title":"Clin Exp Immunol"},{"key":"BFsrep34794_CR19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s007020050108","volume":"105","author":"C Loske","year":"1998","unstructured":"Loske, C. et al. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm 105, 1005\u20131015 (1998).","journal-title":"J Neural Transm"},{"key":"BFsrep34794_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(01)02174-7","volume":"312","author":"W Deuther-Conrad","year":"2001","unstructured":"Deuther-Conrad, W. et al. Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism. Neurosci Lett 312, 29\u201332 (2001).","journal-title":"Neurosci Lett"},{"key":"BFsrep34794_CR21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1464-5491.1999.00015.x","volume":"16","author":"J Muchova","year":"1999","unstructured":"Muchova, J. et al. Antioxidant systems in polymorphonuclear leucocytes of Type 2 diabetes mellitus. Diabet Med 16, 74\u201378 (1999).","journal-title":"Diabet Med"},{"key":"BFsrep34794_CR22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/clpt.1987.50","volume":"41","author":"JT Slattery","year":"1987","unstructured":"Slattery, J. T., Wilson, J. M., Kalhorn, T. F. & Nelson, S. D. Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans. Clin Pharmacol Ther 41, 413\u2013418 (1987).","journal-title":"Clin Pharmacol Ther"},{"key":"BFsrep34794_CR23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/15563659809028022","volume":"36","author":"AL Jones","year":"1998","unstructured":"Jones, A. L. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J Toxicol Clin Toxicol 36, 277\u2013285 (1998).","journal-title":"J Toxicol Clin Toxicol"},{"key":"BFsrep34794_CR24","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","volume":"341","author":"N Joshi","year":"1999","unstructured":"Joshi, N., Caputo, G. M., Weitekamp, M. R. & Karchmer, A. W. Infections in patients with diabetes mellitus. N Engl J Med 341, 1906\u20131912 (1999).","journal-title":"N Engl J Med"},{"key":"BFsrep34794_CR25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.26.2.510","volume":"26","author":"BR Shah","year":"2003","unstructured":"Shah, B. R. & Hux, J. E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26, 510\u2013513 (2003).","journal-title":"Diabetes Care"},{"key":"BFsrep34794_CR26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10096-011-1337-4","volume":"31","author":"GC Koh","year":"2012","unstructured":"Koh, G. C., Peacock, S. J., van der Poll, T. & Wiersinga, W. J. The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis 31, 379\u2013388 (2012).","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BFsrep34794_CR27","unstructured":"WHO. Global status report on noncommunicable disease 2010. World Health Organization: WHO Press (2010)."},{"key":"BFsrep34794_CR28","unstructured":"WHO. WHO model list of essential medicines. (2015)."},{"key":"BFsrep34794_CR29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0306-3623(97)00277-2","volume":"30","author":"N Kilic","year":"1998","unstructured":"Kilic, N., Malhatun, E., Elmali, E. & Altan, N. An investigation into the effect of sulfonylurea glyburide on glutathione peroxidase activity in streptozotocin-induced diabetic rat muscle tissue. Gen Pharmacol 30, 399\u2013401 (1998).","journal-title":"Gen Pharmacol"},{"key":"BFsrep34794_CR30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jdiacomp.2007.09.001","volume":"23","author":"NK Nazaroglu","year":"2009","unstructured":"Nazaroglu, N. K., Sepici-Dincel, A. & Altan, N. The effects of sulfonylurea glyburide on superoxide dismutase, catalase, and glutathione peroxidase activities in the brain tissue of streptozotocin-induced diabetic rat. J Diabetes Complications 23, 209\u2013213 (2009).","journal-title":"J Diabetes Complications"},{"key":"BFsrep34794_CR31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1753-0407.2012.00187.x","volume":"4","author":"R Gupta","year":"2012","unstructured":"Gupta, R., Sharma, A. K., Sharma, M. C. & Gupta, R. S. Antioxidant activity and protection of pancreatic beta-cells by embelin in streptozotocin-induced diabetes. J Diabetes 4, 248\u2013256 (2012).","journal-title":"J Diabetes"},{"key":"BFsrep34794_CR32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.numecd.2007.05.003","volume":"18","author":"MP Lu","year":"2008","unstructured":"Lu, M. P. et al. Modulation of methylglyoxal and glutathione by soybean isoflavones in mild streptozotocin-induced diabetic rats. Nutr Metab Cardiovasc Dis 18, 618\u2013623 (2008).","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"BFsrep34794_CR33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/diab.35.5.503","volume":"35","author":"D Loven","year":"1986","unstructured":"Loven, D. et al. Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozocin-induced diabetes. Diabetes 35, 503\u2013507 (1986).","journal-title":"Diabetes"},{"key":"BFsrep34794_CR34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/340042","volume":"185","author":"P Villa","year":"2002","unstructured":"Villa, P., Saccani, A., Sica, A. & Ghezzi, P. Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense. J Infect Dis 185, 1115\u20131120 (2002).","journal-title":"J Infect Dis"},{"key":"BFsrep34794_CR35","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1172\/JCI31097","volume":"117","author":"AR Martineau","year":"2007","unstructured":"Martineau, A. R. et al. Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 117, 1988\u20131994 (2007).","journal-title":"J Clin Invest"},{"key":"BFsrep34794_CR36","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/eji.201344219","volume":"44","author":"A Dorhoi","year":"2014","unstructured":"Dorhoi, A. et al. Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics. Eur J Immunol 44, 2380\u20132393 (2014).","journal-title":"Eur J Immunol"},{"key":"BFsrep34794_CR37","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1128\/IAI.70.7.3953-3958.2002","volume":"70","author":"GC Ulett","year":"2002","unstructured":"Ulett, G. C. et al. Analogous cytokine responses to Burkholderia pseudomallei strains contrasting in virulence correlate with partial cross-protection in immunized mice. Infection and Immunity 70, 3953\u20133958 (2002).","journal-title":"Infection and Immunity"},{"key":"BFsrep34794_CR38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1465-9921-8-48","volume":"8","author":"TH Harju","year":"2007","unstructured":"Harju, T. H. et al. Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients. Respir Res 8, 48 (2007).","journal-title":"Respir Res"},{"key":"BFsrep34794_CR39","doi-asserted-by":"crossref","first-page":"e29539","DOI":"10.1371\/journal.pone.0029539","volume":"6","author":"RC Coll","year":"2011","unstructured":"Coll, R. C., Robertson, A., Butler, M., Cooper, M. & O\u2019Neill, L. A. The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes. PLoS ONE 6, e29539 (2011).","journal-title":"PLoS ONE"},{"key":"BFsrep34794_CR40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF00320487","volume":"49","author":"M Markert","year":"1984","unstructured":"Markert, M., Cech, P. & Frei, J. Oxygen metabolism of phagocytosing human polymorphonuclear leucocytes in diabetes mellitus. Blut 49, 447\u2013455 (1984).","journal-title":"Blut"},{"key":"BFsrep34794_CR41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-2007-1019044","volume":"14","author":"PV Subbaiah","year":"1982","unstructured":"Subbaiah, P. V. & Bagdade, J. D. Host defense mellitus: defective membrane synthesis during phagocytosis. Horm Metab Res 14, 445\u2013448 (1982).","journal-title":"Horm Metab Res"},{"key":"BFsrep34794_CR42","first-page":"425","volume":"2","author":"TR Jerrells","year":"1994","unstructured":"Jerrells, T. R., Slukvin, I., Sibley, D. & Fuseler, J. Increased susceptibility of experimental animals to infectious organisms as a consequence of ethanol consumption. Alcohol Alcohol Suppl 2, 425\u2013430 (1994).","journal-title":"Alcohol Alcohol Suppl"},{"key":"BFsrep34794_CR43","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","volume":"25","author":"SM Opal","year":"1997","unstructured":"Opal, S. M. et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 25, 1115\u20131124 (1997).","journal-title":"Crit Care Med"},{"key":"BFsrep34794_CR44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.micinf.2014.07.007","volume":"16","author":"AM Gamage","year":"2014","unstructured":"Gamage, A. M., Lee, K. O. & Gan, Y. H. Effect of oral N-acetyl cysteine supplementation in type 2 diabetic patients on intracellular glutathione content and innate immune responses to Burkholderia pseudomallei. Microbes Infect 16, 661\u2013671 (2014).","journal-title":"Microbes Infect"},{"key":"BFsrep34794_CR45","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1177\/014860719902300515","volume":"23","author":"H Saito","year":"1999","unstructured":"Saito, H., Furukawa, S. & Matsuda, T. Glutamine as an immunoenhancing nutrient. JPEN J Parenter Enteral Nutr 23, S59\u2013S61 (1999).","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"BFsrep34794_CR46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0731-7085(02)00013-4","volume":"28","author":"I Niopas","year":"2002","unstructured":"Niopas, I. & Daftsios, A. C. A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis 28, 653\u2013657 (2002).","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"BFsrep34794_CR47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/cyto.990150411","volume":"15","author":"DW Hedley","year":"1994","unstructured":"Hedley, D. W. & Chow, S. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 15, 349\u2013358 (1994).","journal-title":"Cytometry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep34794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34794","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T02:26:33Z","timestamp":1672885593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep34794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep34794"],"URL":"https:\/\/doi.org\/10.1038\/srep34794","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,7]]},"assertion":[{"value":"13 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34794"}}